Clinical significance of gut microbiota-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus

Jiwon Yang, Youngjae Park, Se Gwang Jang, Min-Jung Park, Su-Jin Moon, Hyung-Kyoon Choi, Seung-Ki Kwok · 2026

Read Clinical significance of gut microbiota-derived metabolite trimethylamine N-oxide in patients with systemic lupus erythematosus by Jiwon Yang, Youngjae Park, Se Gwang Jang, Min-Jung Park, Su-Jin Moon, Hyung-Kyoon Choi, Seung-Ki Kwok (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13408999.txt.

Description

Jiwon Yang and team weighed a gut microbe metabolite, trimethylamine N-oxide, in systemic lupus erythematosus and its heart disease link. Their 2026 work enrolls 157 lupus patients and 50 healthy controls, gauging serum metabolite levels, fecal precursors, and gut microbiota make-up. Lupus carries sharply higher heart risk, and the metabolite spurs inflammation and atherosclerosis, yet its lupus role had been unclear.

Lupus patients with heart disease showed clearly higher metabolite levels than controls and lupus patients with no heart disease. Serum metabolite and fecal precursor levels rose with cumulative organ damage scores, while serum metabolite levels fell as steroid dose rose. Gut microbiota differed between lupus patients with and without heart disease. The work ties gut metabolism to lupus heart risk and damage, with steroid modulation noted.

Catalog record

CREATORJiwon Yang, Youngjae Park, Se Gwang Jang, Min-Jung Park, Su-Jin Moon, Hyung-Kyoon Choi, Seung-Ki Kwok
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE39 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13408999

Browse the full library · About the Tower of Babel